Concepedia

Oliver Staak

OS

Statistics

Publications

6

Citations

388

H-Index

6

Active since

2002

Affiliations

University of Cologne(Current)

University Hospital Cologne

Oliver Staak is an author at University of Cologne specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2002–2010

6

Publications

6

A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.

Roland Schnell, Oliver Staak, Peter Borchmann et al. · PubMed · 2002 · 136 citations

Medicine, Oncology, Pharmacology +16

The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma

Peter Borchmann, Hinrich P. Hansen, Claudia Gottstein et al. · Blood · 2003 · 111 citations · Full text

Medicine, Immunology, Oncology +11

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study

Andreas Josting, Michal Sieniawski, J. Glossmann et al. · Annals of Oncology · 2005 · 62 citations · Full text

Medicine, Oncology, Chemotherapy +15

Imaging of central nervous system lymphomas with iodine‐123 labeled rituximab

Markus Dietlein, Hendrik Pels, H. Schulz et al. · European Journal Of Haematology · 2005 · 40 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

Michal Sieniawski, Oliver Staak, Jan‐Peter Glossmann et al. · Annals of Hematology · 2006 · 28 citations

Medicine, Oncology, Pharmacotherapy +13

1–5 of 6